4//SEC Filing
MCENANY PATRICK J 4
Accession 0001161697-25-000185
CIK 0001369568other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:00 PM ET
Size
7.0 KB
Accession
0001161697-25-000185
Insider Transaction Report
Form 4
MCENANY PATRICK J
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-06-06$25.95/sh−28,252$732,998→ 4,453,450 total - Sale
Common Stock, par value $0.001 per share
2025-06-09$26.11/sh−171,748$4,484,340→ 4,281,702 total
Footnotes (3)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range from $25.906 to $25.95 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in a range from $25.765 to $26.46 per share.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0000929985
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:00 PM ET
- Size
- 7.0 KB